Background-Substrate utilization in tissues with high energetic requirements could play an important role in cardiometabolic disease. Current techniques to assess energetics are limited by high cost, low throughput, and the inability to resolve multiple readouts simultaneously. Consequently, we aimed to develop a multiplexed optical imaging platform to simultaneously assess energetics in multiple organs in a high throughput fashion. Methods and Results-The detection of 18F-Fluordeoxyglucose uptake via Cerenkov luminescence and free fatty acid uptake with a fluorescent C 16 free fatty acid was tested. Simultaneous uptake of these agents was measured in the myocardium, brown/white adipose tissue, and skeletal muscle in mice with/without thoracic aortic banding. Within 5 weeks of thoracic aortic banding, mice developed left ventricular hypertrophy and brown adipose tissue activation with upregulation of β 3 AR (β 3 adrenergic receptors) and increased natriuretic peptide receptor ratio. Imaging of brown adipose tissue 15 weeks post thoracic aortic banding revealed an increase in glucose (P<0.01) and free fatty acid (P<0.001) uptake versus controls and an increase in uncoupling protein-1 (P<0.01). Similar but less robust changes were seen in skeletal muscle, while substrate uptake in white adipose tissue remained unchanged. Myocardial glucose uptake was increased post-thoracic aortic banding but free fatty acid uptake trended to decrease. Conclusions-A multiplexed optical imaging technique is presented that allows substrate uptake to be simultaneously quantified in multiple tissues in a high throughput manner. The activation of brown adipose tissue occurs early in the onset of left ventricular hypertrophy, which produces tissue-specific changes in substrate uptake that may play a role in the systemic response to cardiac pressure overload. (Circ Cardiovasc Imaging. 2018;11:e007007. DOI: 10.1161/ CIRCIMAGING.117.007007.)
T he regulation of substrate utilization and energy metabolism is of fundamental importance in tissues with high metabolic rates and abundant mitochondria, such as the heart and brown adipose tissue (BAT). Traditional metabolic imaging techniques such as positron emission tomography and magnetic resonance spectroscopy, 1 while providing valuable insights, have several limitations, including low throughput, high complexity, high cost, and the inability to image multiple metabolic processes simultaneously. Optical imaging techniques can overcome many of these limitations and are being extensively used in cardiovascular investigation. [2] [3] [4] [5] However, optical techniques, as of yet, have not been used to investigate energy metabolism in the heart or other tissues.
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Changes in substrate utilization in the heart have been linked to adaptive, maladaptive, and pathological processes. [6] [7] [8] [9] However, little is known about the changes in substrate metabolism in BAT and other systemic tissues in the setting of pathological heart disease, such as cardiac pressure overload. Recent studies have expanded the role of BAT from nonshivering thermogenesis to include whole body energy regulation, insulin sensitivity, and neurohormonal signaling in heart failure. 10, 11 The traditional mechanism for BAT activation has been through cold stimulation, likely mediated by the sympathetic nervous system and β 3 AR (β 3 adrenergic receptors), 12, 13 but recent work has shown that natriuretic peptides can also activate BAT. 14 The principal aim of the current study was to explore the influence of cardiac pressure overload and consequent left ventricular (LV) hypertrophy (LVH) on substrate uptake in the body. We hypothesized that a novel, multiplexed optical imaging approach, involving Cerenkov luminescence imaging (CLI) of glucose 15, 16 and fluorescence imaging of free fatty acids (FFA), would allow substrate uptake in multiple tissues to be assessed in a relatively low cost and high throughput fashion. We further hypothesized that this technique would reveal changes in BAT metabolism in response to cardiac pressure overload and LVH.
Methods

Mouse Model of LVH
LVH was induced by thoracic aortic banding (TAC) in 10-week-old female C57BL/6 mice (n=25), as previously described. 17 In brief, after the chest was opened and aortic arch visualized, a 27-gauge needle was placed adjacent to the aorta. An 8-0 suture was then used to occlude the needle around the ascending aorta. After occlusion, the needle was removed, the chest closed, and the animals were allowed to recover. Agematched healthy female C57BL6 mice (n=26) were used as controls. All surgical procedures were performed in accordance with animal protocols approved by the Institutional Animal Care and Use Committee of Massachusetts General Hospital. The data, analytic methods, and study materials will not be made available to other researchers for purposes of reproducing the results or replicating the procedure.
Cardiac Phenotype by Magnetic Resonance Imaging After TAC
In vivo cardiac magnetic resonance imaging (MRI) was performed at 5 (n=9) and 15 weeks (n=8) after TAC to assess cardiac morphology and function. Gradient echo cine images were acquired at 9.4 Tesla (Biospec, Bruker, Billerica, MA) in the short axis of the left ventricle using cardiorespiratory gating (SA Instruments, Stonybrook, NY) as previously described 18, 19 and with the following parameters: field of view 2.5×2.5 cm 2 , slice thickness 1 mm, matrix, 192×192, flip angle 30°, 20 frames per R-R interval, echo time 1.6 ms, 4 averages. Image analysis was performed using Osirix (v5.8.5). Ejection fraction (EF) was calculated using the Simpson's method of discs as previously described. 20 Similarly, the epicardial and endocardial borders were traced, and the LV mass was calculated by the following equation: Σ(LV epi −LV endo )×1.05 g/cm 3 .
Polymerase Chain Reaction and Western Blotting
Separate cohorts of TAC mice were euthanized at 5 (n=4) and 15 weeks (n=4) to assess BAT morphology, weight, and metabolic profile (control n=5 for both time points). The wet weight of tissues was measured and then snap frozen in liquid nitrogen. Samples were ground under liquid nitrogen, and total RNA was extracted with an RNeasy Tissue Lipid Kit (Qiagen). Total RNA was converted to cDNA, and quantitative polymerase chain reaction for key enzymes of BAT metabolism was performed 21 (see Data Supplement). UCP1 (uncoupling protein-1) levels in BAT were measured. Frozen BAT samples were homogenized in SDS lysis buffer. Equal amounts of total protein were separated by SDS-PAGE on 10% gels and transferred to polyvinylidene fluoride membrane. UCP1 was detected using UCP1 primary antibody (Abcam) and normalized to αTubulin (Calbiochem; see Data Supplement).
In Vitro Validation of Optical Signals
Calibration of the optical signals from 18F-Fluorodeoxyglucose (18F-FDG) and boron-dipyrromethene (BODIPY)-labeled FFA analog BODIPY FL C 16 (4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diazas-indacene-3-hexadecanoic acid; Thermo Fisher Scientific; FFA) was performed by imaging a range of known concentrations of each probe in vitro (see Data Supplement).
Ex Vivo Validation of Cerenkov Luminescence
Further validation of the Cerenkov luminescence signal was performed in mice (C57BL6; Jackson Laboratories, Bar Harbor, Maine) with myocardial infarction, providing distinct areas of normal/abnormal myocardial metabolism. Myocardial infarction was induced in female C57BL6 mice (n=3) by coronary ligation, as previously described. 18 Two days post-myocardial infarction, the mice were injected via the intraperitoneal route with 0.05 mCi/g of 18F-FDG. The 18F-FDG was allowed to circulate for 1 hour while the animals were active, after which time they were euthanized and the heart excised, sectioned, and imaged with CLI. After CLI, the sections were stained with triphenyltetrazolium chloride and imaged using a conventional light stereomicroscope. 22 The percent viable area by 18F-FDG was correlated with the percent viable area by triphenyltetrazolium chloride for each slice (see Data Supplement).
Multiplexed Optical Imaging of Substrate Uptake
At 15 weeks post TAC, mice were simultaneously injected intraperitoneally with 0.05 mCi/g of 18 F-FDG diluted in PBS and 1 nmol/g of BODIPY C 16 FFA diluted in PBS, 7% DMSO, and 4% fatty acid-free BSA. Final volume of injection for each probe was 100 μL. Total in vivo circulating time for 18F-FDG was 60 and 30 minutes for BODIPY C 16 FFA. Animals were subsequently euthanized and tissues were harvested. Intrascapular BAT was dissected from surrounding white adipose tissue (WAT) using a light microscope. Whole hearts were sectioned into short-axis slices (3-4 slices per heart). Epididymal WAT and quadriceps skeletal muscle were also harvested. The tissues were immediately washed in ice cold PBS and imaged using the IVIS Spectrum imaging system (see Data Supplement).
Analysis of the optical images was performed using the Living Image v4.5 software package (PerkinElmer, Boston, MA). A region of interest was drawn manually around the tissues. Radiance (photons/s per cm 2 per sr) was calculated for 18F-FDG and radiant efficiency (radiance/μW per cm 2 ) was calculated for BODIPY C 16 FFA. An equivalently sized region of interest was drawn adjacent to the tissue and served as the background signal, which was subtracted from the average radiance and average radiant efficiency.
In Vivo Cerenkov Luminescence Imaging of the Heart
Female nu/nu mice (n=5) were anesthetized with isoflurane balanced with oxygen for 5 minutes and injected with either saline (control) or 18F-FDG (250 µCi, n=4) intravenously via the tail vein. Luminescence imaging was performed in the mice 30 minutes after 18F-FDG injection with the following parameters: open filter, F-stop =1, binning=4, field of view=22×22 cm 2 , and exposure time =120 s. Smoothing (3×3) was performed post image acquisition.
Statistical Analysis
Comparison between 2 groups was performed with either a MannWhitney U test or unpaired t test based on the normality of the data. Comparison between greater than 2 groups was performed with analysis of variance and a Tukey's post-test comparison. Two-tailed probability values are reported, and statistical significance is defined as P<0.05. Correlations, when appropriate, were performed using Spearman correlation. Values are reported as mean±standard deviation (SD). All statistical analyses were performed using Prism v6.0 (Graphpad Software Inc, LaJolla, CA).
Results
Cardiac Phenotype
At 5 weeks post-TAC, LV mass was increased by 35% compared with age-matched controls (P<0.05), whereas end diastolic volume, end systolic volume, and EF were not different Optical Metabolic Imaging of Brown Adipose Tissue (Figure 1 ). At 15 weeks post-TAC, LV mass was also increased by 38% compared with age-matched controls (P<0.05; Figure 1) . There was no difference in LV mass at 5 weeks post-TAC compared with that at 15 weeks post-TAC. At 15 weeks post-TAC, end diastolic volume remained stable, whereas end systolic volume trended upward in the banded animals. A significant reduction in EF (P<0.05; Figure 1 ) was seen between the banded mice at 15 and 5 weeks, as well as between banded mice and age-matched control mice. Consistent with the MRI mass measurements, heart weight was increased 5 weeks post-TAC and remained stable at 15 weeks (Figures 2A and 3A , respectively). Thus, as is typical of this model, aortic banding led to LVH by 5 weeks and a progression to mild systolic dysfunction by 15 weeks.
BAT Phenotype 5 Weeks Post-TAC
At 5 weeks, there were no significant differences in body weight (24±1 versus 22±1 g) or BAT wet weight between control and banded animals ( Figure 2B ). Quantitative reverse transcriptase polymerase chain reaction showed a 2.5× increase in mRNA expression for the β 3 AR in BAT from banded mice (P=0.032) and a 48% decrease (P=0.016) in the NPRc (natriuretic peptide clearance receptor; Figure 2C ). There was no significant change in the NPRa (natriuretic peptide active receptor) in BAT, but the NPRa/c ratio, which determines the natriuretic peptide bioactivity in a tissue, 11, 23 was increased 2.8-fold (P=0.005) in the BAT of banded animals. These receptor changes suggest BAT was activated in banded animals. However, downstream to these receptors, only FATP1 (fatty acid transporter Figure 2E and 2F). A nonsignificant decrease in UCP1 mRNA was seen at 5 weeks (data not shown), in agreement with a recent report. 24 However, UCP1 protein abundance was unchanged in banded animals ( Figure 2D; P=0.62) . Thus, at 5 weeks post-TAC, there was little evidence of a change in the downstream metabolic profile in BAT, and accordingly, optical imaging of substrate uptake was deferred until 15 weeks post-TAC.
BAT Phenotype 15 Weeks Post-TAC
By 15 weeks post-TAC, BAT wet weight in banded mice had decreased by 40% (P=0.0001) versus control animals (Figure 3) , while there was no difference in body weights (25±1 versus 23±1 g) between the 2 groups. Similar to 5 weeks post-TAC, there was a 2.5× increase in mRNA for β 3 AR in BAT from banded mice (P=0.004), although the increase in the NPRa/c ratio no longer reached significance (Figure 3; P=0.3) . Similar to the 5-week time point, FATP1 was increased (2.1×) at the 15-week time point in banded animals (P=0.003). However, in contrast to 5 weeks post-TAC, there was also a 20% increase in MCAD mRNA (P=0.04), a 71% increase in GLUT4 mRNA (P=0.002), and a trend toward increased CPT1B mRNA expression ( Figure 3E and 3F) . Moreover, at 15 weeks, there was a 2-fold increase (P=0.010) in the quantity of UCP1 protein in BAT from banded versus control animals ( Figure 3D ). Thus, by 15 weeks post-TAC, there was evidence of increased BAT metabolism as reflected by upregulation of enzymes involved in both glucose and fat metabolism and increased abundance of UCP1. All optical imaging was therefore performed at this time point.
Calibration and Validation of Optical Imaging Platform
Prior to applying the optical imaging platform to the TAC model of LVH, in vitro and ex vivo analyses were performed. There was an excellent correlation (R 2 = 0.99) between 18F-FDG activity and the average radiance measured optically (CLI; Figure IA 
Optical Imaging of Substrate Uptake
Multiplexed optical imaging, performed at 15 weeks post-TAC, showed a 70% increase in glucose uptake in the hearts Figure 2 . Brown adipose tissue (BAT) morphology and activation state 5 weeks post thoracic aortic banding (TAC). At 5 weeks post TAC, there was a significant increase in heart wet weight in banded animals (A) but no significant difference in BAT wet weight (B). In BAT from banded animals, there was a significant increase in β 3 AR (β 3 adrenergic receptor) mRNA. Although there was no change in the natriuretic peptide active receptor (NPRa) levels, there was a significant decrease in natriuretic peptide clearance receptor (NPRc) receptor levels, leading to a significantly increased NPRa/c ratio (C). UCP1 (uncoupling protein-1) protein levels (D) were unchanged between groups at 5 weeks (normalized to α-tubulin which was unchanged between groups). There was a significant increase in FATP1 (fatty acid transporter 1) but remaining key enzymes involved in free fatty acid (FFA) uptake and metabolism were unchanged (E) and key enzymes in glucose uptake and metabolism (F) also remained unchanged. (* P<0.05, **P<0.01, ***P<0.001). CPT1B indicates carnitine palmitoyltransferase 1b; GLUT1, glucose transporter 1; GLUT4, glucose transporter 4; MCAD, medium-chain acyl-CoA dehydrogenase; and PDK4, pyruvate dehydrogenase kinase 4. Optical Metabolic Imaging of Brown Adipose Tissue of banded versus control animals ( Figure 4A ; P=0.011). Although there was a trend toward lower FFA uptake in the hearts from banded animals, this did not reach significance (P=0.5). Glucose uptake in BAT in the 15-week banded mice was 2.7-fold higher compared with BAT from control mice ( Figure 4B ; P=0.002), and there was a 1.9-fold increase in FFA uptake ( Figure 4B ; P=0.0004). Skeletal muscle from banded animals showed a pattern that was similar but less robust than BAT, with a 33% increase in glucose uptake (P=0.022) and a 2-fold increase in FFA uptake ( Figure 5A ; P=0.041). In contrast to the pattern in BAT, there were no significant differences in glucose or FFA uptake in WAT ( Figure 5B ). Four distinct, and tissue-specific, metabolic patterns were, thus, detected in the banded mice at 15 At 15 weeks post TAC, there was a significant increase in heart wet weight (A) and a significant decrease in BAT wet weight (B) in banded vs control animals. In BAT from banded animals, there was a significant increase in β 3 AR (β 3 adrenergic receptor) mRNA; however, there was no significant change in the natriuretic peptide active receptor (NPRa) or natriuretic peptide clearance receptor (NPRc) receptor levels (C). Although a trend toward an increased NPRa/c ratio remained present, it was not significant. Unlike the 5-week time point, UCP1 (uncoupling protein-1) protein levels (D) were significantly increased in the banded animals at 15 weeks (normalized to α-tubulin which was unchanged between groups). There was a significant increase in both FATP1 (fatty acid transporter 1) and MCAD (medium-chain acyl-CoA dehydrogenase) mRNA between the 2 groups and a trend toward increased CPT1B (carnitine palmitoyltransferase 1b; E). Transcript levels of GLUT1 (glucose transporter 1) and PDK4 (pyruvate dehydrogenase kinase 4) were unchanged between the 2 groups at 15 weeks post TAC; however, there was a significant increase in GLUT4 (glucose transporter 4) mRNA in the BAT of banded vs control animals (*P<0.05, **P<0.01, ***P<0.001). weeks, as summarized in the Table. Absolute values for the optical readouts above are provided in Table I in the Data Supplement.
In Vivo Cerenkov Luminescence Imaging
CLI could be successfully performed in all 5 mice. Mice injected with saline did not exhibit any luminescence (Figure 6A) , whereas a robust signal was visible in the upper thorax of all mice injected with 18F-FDG ( Figure 6B ), consistent with cardiac glucose uptake.
Discussion
Optical imaging approaches have been extensively used to study cell biology in the cardiovascular system 4,5 but have hitherto not been applied to study energetics or metabolism in whole organs. Here we describe an approach based on Cerenkov luminescence to study multiple metabolic processes and organs in a high throughput manner. This multiplexed technique allowed glucose and FFA uptake, in a model of LVH, to be simultaneously assessed in the myocardium, BAT, WAT, and skeletal muscle. The increase in glucose and FFA uptake observed in BAT during the transition from LVH with a preserved to reduced EF suggests that altered substrate metabolism in BAT could be a feature associated with advanced LVH.
Fluorescence imaging of glucose uptake has previously been attempted with molecules such as 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose. 25 However, the transport kinetics of these agents are likely governed by the bulky, hydrophobic fluorophore, rather than the small hydrophilic glucose molecule itself. 26 In contrast, 18F-FDG is inert and has been used extensively to assess glucose uptake with positron emission tomography. While the current study was limited to the imaging of glucose and FFAs, conceptually 4 to 5 spectrally resolvable substrates could be imaged simultaneously with this approach. While imaging in the current study was performed ex vivo to demonstrate proof-ofprinciple, our approach is well suited to in vivo imaging with fluorescence tomography. As an initial step in this direction, we show that Cerenkov images of FDG uptake in the mouse heart can be acquired in vivo. Efforts to combine this with fluorescence imaging of fatty acid uptake in vivo are currently underway. This will allow the relevance of altered substrate uptake to be imaged, with our approach, under the full range of physiological conditions, relevant to clinical pathophysiology including LVH and heart failure with reduced and preserved EF.
The identification of depots of BAT in adult humans has prompted interest in its role in human physiology. 27, 28 Recent studies have suggested that communication between the heart and BAT is possibly mediated through sympathetic stimulation and natriuretic peptides. [11] [12] [13] [14] In addition, there may be reciprocal communication between BAT and the heart, as BAT has been shown to modulate cardiomyocyte injury. 29 MRI produces strong endogenous contrast in BAT, allowing it to be imaged and differentiated from WAT. 30 Moreover, our group recently showed, using functional MRI techniques, that BAT is activated in a murine model of heart failure with reduced EF and that this activation consumes internal BAT lipid stores. This resulted in a decrease in BAT volume, as measured by MRI, and smaller lipid droplets in BAT measured by histology. 20 Here, we extend these physiological observations and show that BAT is similarly activated in a model of LVH with a similar reduction in BAT mass. The pattern of BAT activation, however, was highly influenced by the duration of hypertrophy and the transition from a preserved to reduced EF.
The response of the heart to TAC can vary depending on animal strain, sex, and surgical technique. 31, 32 In the current study, at 5 weeks post-TAC, the mice showed signs of LV hypertrophy but preserved cardiac function by MRI. However, at 15 weeks post-TAC, many of the mice began showing signs of mild dysfunction with decreased EF. Despite no sign of decompensation at the 5-week time point, an increase in the upstream receptors responsible for BAT activation (increased β 3 AR and increased NPRa/c ratio) was seen, suggesting that BAT signaling was affected by TAC physiology. In a recent report, changes in β 3 AR mRNA in BAT were not observed 6 weeks post-TAC 24 ; however, differences in sex and technique may account for this difference. Increases in β 3 AR and the NPRa/c ratio have been shown to occur in beiging of WAT, 33, 34 and our data suggest that a similar phenomenon may occur early in the process of chronic BAT activation associated with LVH. However, this early activation of BAT was not associated with downstream changes in mRNA of most of the key enzymes involved in substrate utilization (apart from FATP1), BAT weight, or UCP1 protein levels.
At 15 weeks post-TAC, consistent with traditional concepts of increased BAT activity, UCP1 protein was significantly increased. 35, 36 In addition, markers of increased uptake and handling of FFA (FATP1, CPT1B, and MCAD) trended up or were significantly increased, and markers of glucose uptake (GLUT4) were also significantly increased. Although the enzymes selected for analysis were not an exhaustive list of potential mediators of substrate utilization, these data corroborated our imaging findings, which showed an increase in both glucose and FFA uptake in BAT at 15 weeks. Further studies examining protein expression, enzyme activity, and phosphorylation states of the enzymes involved in glucose and fatty acid metabolism in BAT will be required to fully understand the signaling mechanisms. The activation of BAT in LVH may be adaptive or maladaptive and will also require further study. Increased BAT activity could provide a mechanism for cardiac cachexia, which is frequently seen in patients with end-stage heart failure. 37 The changes we observed in myocardial substrate uptake have been well described in diseased myocardium 9, [38] [39] [40] [41] [42] and further validate our optical approach. To the best of our knowledge, this is the first description of altered substrate uptake in BAT during LVH, which resembles the response of BAT to cold stimulation. 43 The elevation in UCP1 seen 15 weeks post-TAC strongly suggests that the increased substrate uptake is being used for uncoupled respiration in activated BAT. However, a limitation of all labeled imaging substrates is the inability to differentiate uptake from utilization. Hyperpolarized MRI holds significant promise in this regard, and its strengths/limitations are highly complementary to the high throughput optical approach we describe here. The breadth of our approach allowed us to identify major differences in the response of BAT, skeletal muscle, and WAT to TAC. Our results are consistent with recent data, suggesting that BAT and skeletal muscle have cell lineage progenitors in common and with different proteomic profiles than WAT. 44, 45 In conclusion, a new platform to simultaneously study several aspects of substrate uptake and energy metabolism is presented. This multiplexed approach leverages the strength of optical imaging to examine multiple processes in multiple tissues in a simple and high throughput fashion. Although the use of positron emission tomography and magnetic resonance spectroscopy will remain vital in human translation, 46 they are complex techniques and are less suited to high-throughput preclinical studies. The multiplexed optical approach described here provides a rapid and broad assay of energetics in all metabolically active tissues in the body, the value of which is demonstrated by the detection of altered BAT metabolism in LVH. Further study of this phenomenon is warranted to define more fully the role of BAT activation at different stages of heart failure and its potential interaction with the heart.
